From: Pros and cons of tetrastarch solution for critically ill patients
Product | Concentration (%) | Oncotic pressure (mmHg) | Initial volume expansiona(%) | Persistence in the body (days) | Maximal dose/24Â h | Carrier solution | Effect on hemostasis | Comments |
---|---|---|---|---|---|---|---|---|
Albumin | 4 | 20–29 | 80 | n/a |  | Na 148 mEq/l | 0 |  |
20 | 100–120 | 200 ~ 400 | Cl 128 mEq/l | |||||
Na n/a | ||||||||
Cl 19Â mEq/l | ||||||||
Dextran 70 | 6 | 56–68 | 120 | 28 ~ 42 | 1.5 g/kg |  | +++ |  |
Dextran 40 | 10 | 168–191 | 200 | 6 | 1.5 g/kg |  | +++ |  |
Fluid gelatin | 4 | 42 | 70 | 2 ~ 7 |  | Na 154 mEq/l | 0 ~ + |  |
90 | 7 | |||||||
Cl 120Â mEq/l | ||||||||
Urea-linked gelatin | 3.5 | 25–29 | 70 ~ 80 | 2 ~ 7 |  | Na 145 mEq/l | 0 ~ + |  |
Cl 145Â mEq/l | ||||||||
HES 670/0.75 | 6 | 25–30 | 100 |  | 20 ml/kg | Lactate Ringer | ++(+) |  |
HES 200/0.5 | 6 | 30–37 | 100 | 3 ~ 4 | 33 ml/kg |  | + |  |
HES 70/0.5 | 6 |  | 80 ~ 90 |  | 20 ml/kg | Either saline or balanced solution | 0 ~ + |  |
HES 200/0.5 | 10 | 59–82 | 145 | 3 ~ 4 | 20 ml/kg |  | + | Used in VICEP study [12] |
HES 130/0.4 | 6 | 36 | 100 | <1 | 50 ml/kg | Either saline or similar to acetate Ringer but no Ca | 0 ~ + | |
HES 130/0.42 | 6 | Â | Â | Â | 33Â ml/kg | Acetate Ringer | Â | Used in 6S trial [15] |